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Over the past few years, it has become increasingly apparent that signal transduction pathways are not merely linear cascades;
they are organized into complex signaling networks that require high levels of regulation to generate precise and unique cell
responses. However, the underlying regulatory mechanisms by which signaling pathways cross-communicate remain poorly
understood. Here we show that the Ras-binding protein Canoe (Cno)/AF-6, a PDZ protein normally associated with cellular
junctions, is a key modulator of Wingless (Wg)/Wnt, Ras-Mitogen Activated Protein Kinase (MAPK) and Notch (N) signaling
pathways cross-communication. Our data show a repressive effect of Cno/AF-6 on these three signaling pathways through
physical interactions with Ras, N and the cytoplasmic protein Dishevelled (Dsh), a key Wg effector. We propose a model in
which Cno, through those interactions, actively coordinates, at the membrane level, Ras-MAPK, N and Wg signaling pathways
during progenitor specification.
Citation: Carmena A, Speicher S, Baylies M (2006) The PDZ Protein Canoe/AF-6 Links Ras-MAPK, Notch and Wingless/Wnt Signaling Pathways by
Directly Interacting with Ras, Notch and Dishevelled. PLoS ONE 1(1): e66. doi:10.1371/journal.pone.0000066
INTRODUCTION
In multicellular organisms, cells are exposed to a complex
environment in which they read numerous and sometimes con-
flicting stimuli. Cross-communication between signaling pathways
is crucial for the integration of the multiple intracellular responses
elicited by simultaneous signals, allowing the generation of unique
cell outputs. As a result of cross-communication, networks of signal
interactions are established within the cell. The elucidation of the
underlying mechanisms by which these networks are built and
regulated is essential for the understanding and pharmacological
treatment of pathologies in which signaling pathways are mis-
regulated, such as some neural disorders and cancer [1].
The Drosophila mesoderm provides an excellent system for
studying signaling networks as Drosophila can be subjected to
complex genetic manipulations and multiple signaling pathways
are coordinately involved throughout mesoderm differentiation.
After gastrulation, uncommitted mesodermal cells migrate and
proliferate. Then, autonomous and non-autonomous signals
pattern the mesoderm, allocating regions from which progenitors
of the different mesodermal tissues, such as the somatic muscles
and heart, will arise [2–4]. Somatic muscle and heart progenitors
are singled out from clusters of equivalent cells (‘‘promuscle
groups’’) that express the transcription factor Lethal of scute (L’sc),
in a process reminiscent of neural progenitor specification [5].
These progenitors divide asymmetrically to give rise to two
founder cells [6,7]. Each founder cell is endowed with a unique
identity by expressing specific combinations of transcription
regulators such as Slouch/S59, Kru ¨ppel (Kr) or Even-Skipped
(Eve) [4,8]. We have focused on the specification of a dorsal subset
of muscle and heart progenitors that express the identity protein
Eve [9]. These progenitors differentiate upon the concerted and
combinatorial action of four highly conserved signal transduction
pathways triggered by Wingless (Wg)/Wnt, Decapentaplegic
(Dpp)/TGF-b, Receptor Tyrosine Kinase (RTK)-Ras-MAPK
and Notch (N) [10]. Cross-talk between Ras and N signaling
pathways throughout Eve
+ progenitor specification has been
previously reported [11]. Indeed, crosstalk between N and Ras
signaling pathways is necessary for signal integration in multiple
processes during Drosophila development, as well as in other
invertebrate and vertebrate systems [12–18]. However, the
mechanisms by which N and Ras pathways cross-communicate
are only beginning to be elucidated [19–23].
In this work, we have investigated the function of the Drosophila
PDZ (PSD-95, Dlg, ZO-1) domain-containing protein Canoe
(Cno) as a regulator of N and Ras cross-communication
throughout Eve
+ progenitor specification. cno mutant alleles were
originally isolated by their dorsal open phenotype, hence its name
(Ju ¨rgens et al, 1984). Indeed, Cno has been shown to participate
in the morphogenetic process known as dorsal closure of the
epidermis by modulating the Jun N-terminal kinase (JNK)
signaling cascade (Takahashi et al.1998). cno encodes a cytoplasmic
protein associated with cell junctions in epithelial tissues, where
Cno function has been studied in Drosophila [24,25]. The human
ortholog of Cno, AF-6, was initially identified as a fusion partner of
ALL-1, a product involved in human leukemias [26]. AF-6 also
localizes at epithelial cell junctions where it binds ZO-1, a tight-
junction protein important for cell-cell contacts and cytoskeleton
rearrangement [27,28]. Cno and AF-6 share a similar structure:
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the plasma membrane that contribute to the subcellular spatial
organization of signaling pathways [29–31]; a Kinesin-like domain
and a Myosin-V-like domain, characteristic motifs present in
proteins that interact with cytoskeleton components [32]; and two
Ras-associating motifs [33] through which Cno/AF-6 binds to the
activated form of Ras (Ras
Act) [34]. In Drosophila, Cno interacts
genetically with Ras, during eye development, and with N, during
bristle and wing development [24,35,36]. However, the in-
volvement of Cno in N-Ras cross-talk has not been studied. Here
we propose a model in which Cno mediates N-Ras cross-talk
through Dishevelled (Dsh/Dvl), the most proximal cytoplasmic
component of Wg/Wnt pathway [37–40]. We suggest that Cno,
by binding Ras
Act, Dsh and N, represses the signals that these
proteins trigger and actively coordinates, at the membrane level,
RTK-Ras-MAPK, Dl-N and Wg-Dsh signaling pathways
throughout progenitor specification.
RESULTS
The specification of dorsal somatic muscle/heart progenitors
depends on the combinatorial action of multiple signaling
pathways [10]. First, Wg/Wnt and Dpp/TGF-b, secreted from
the ectoderm to the mesoderm, define a dorsal region (preC2)
revealed by the expression of the transcription factor L’sc. Then,
two RTKs, the Drosophila EGF receptor (Egfr) [41] and the FGF
receptor Heartless (Htl) [42] trigger a positive Ras signal in two
groups of equivalent cells, within the dorsal mesodermal region
prepatterned by Wg and Dpp (cluster C2, shown in Fig. 1, and
cluster C15, not shown). RTK-Ras, through the MAPK module,
upregulates L’sc expression and activates the identity protein Eve
in these clusters, which appear sequentially. In addition, Delta (Dl)
[43] activates its receptor N, promoting a lateral inhibitory signal
among the cells of the equivalence group, so that only one
progenitor is singled out from each cluster (progenitor P2, Fig. 1D–
1F; and progenitor P15, not shown).
Loss-of-function (lof) analysis of Ras-MAPK signaling pathway
components reveals a decrease in the number of progenitors
specified. Conversely, lof mutants of components of N signaling
pathway display an increased number of progenitors. The gain-of-
function (gof) phenotypes have the opposite effect: overexpression
of Ras
Act in the mesoderm leads to the specification of extra
progenitors whereas overexpression of an activated form of N
(N
Act) inhibits progenitor specification [11] (see also Fig. 2D and
2E). These effects are tightly linked, as Ras-MAPK and N
signaling pathways act in concert. A complex network of
competitive and cooperative interactions between Ras and N
signal transduction pathways during muscle/heart progenitor
specification has been documented. For example, N signaling
downregulates the expression of different components of Ras-
MAPK pathway and Ras signaling upregulates the N ligand Dl
[11]. Hence, an accurate regulation of N and Ras signaling
thresholds is critical for the acquisition of a progenitor fate. Since
Cno has been shown to genetically interact with N or Ras
signaling in different tissues and to physically interact with Ras
Act
(see introduction), we analyzed a possible function of Cno during
progenitor formation modulating N-Ras cross-talk.
Cno is expressed in the Drosophila embryonic
mesoderm throughout muscle/heart progenitor
specification
As the first step, we asked whether Cno is expressed in the
mesoderm during progenitor specification. Cno expression was
examined in embryos that carry a twi-CD2 insertion, which drives
the expression of the transmembrane protein CD2 under the
control of a mesoderm-specific twist (twi) promoter. We observed
that Cno was expressed in the mesoderm in a punctuate pattern
close to the cell membrane (Fig. 1A–1C).
To investigate whether Cno was expressed when N and Ras
signaling pathways interact to specify dorsal progenitors, we
analyzed Cno expression with different progenitor markers. Cno
was detected along with L’sc, the earliest and most general
progenitor marker, in the dorsal region pre-patterned by Wg and
Dpp (preC2). Cno was also detected along with the identity
protein Eve in the dorsal Eve
+ equivalence group (C2) and,
subsequently, in the progenitor (P2) (Fig. 1D–1R). Thus, Cno was
expressed in the mesoderm during the time when Ras and N are
regulating the specification of dorsal progenitors.
Figure 1. Cno is expressed in the mesoderm throughout progenitor
specification. (A) Confocal immunofluorescence showing a lateral view
of a late stage 10 embryo. Cno (red) is detected in the mesoderm
(green). (B, C) Higher magnification of two hemisegments (636; inset in
A) reveals punctuate Cno expression at submembrane locations
(arrows). (D–F) Diagrams show the most dorsal part of one hemiseg-
ment and the signals involved throughout dorsal progenitor specifica-
tion. (G–R) Confocal immunofluorescences showing high magnification
(636) of the most dorsal part of one hemisegment. (D, G, J, M) Cno is
expressed in the dorsal mesodermal region pre-patterned by Wg and
Dpp (preC2) along with L’sc. (E, H, K, N, Q) Cno is detected in the
equivalence group in which Ras is locally activated (C2) restricting L’sc
to this cluster and activating Eve. (F, I, L, O, R) Cno is expressed in the
progenitor (P2) singled out from this cluster after N-promoted lateral
inhibition.
doi:10.1371/journal.pone.0000066.g001
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Eve progenitors
To investigate a potential function of Cno in Ras-N crosstalk
during progenitor specification, we analyzed the dorsal Eve
+
progenitors in cno
2 zygotic null mutant embryos. Three different
phenotypes were observed: (1) wildtype-like hemisegments, (2)
hemisegments with extra Eve
+ progenitors and (3) hemisegments
displaying loss of Eve
+ progenitors. Comparable results were
obtained with different cno mutant alleles (Fig. 2B and 2G).
Likewise, the expression of other muscle progenitor markers and
signaling proteins involved in muscle/heart progenitor specifica-
tion were, like Eve, both upregulated or downregulated in different
hemisegments of cno
2 zygotic null mutant embryos (Fig. S1A–
S1R). These effects on muscle progenitor specification were
reflected in the final muscle pattern where gain and loss of specific
body muscles was observed (Fig. S1S–S1V). The progenitor
markers (including Eve) and signaling proteins analyzed (Fig. S1)
are under Ras and N regulation [11]. Indeed, the cno
2 mutant
phenotype resembled a mosaic of Ras and N mutant phenotypes
(Fig. 2A, 2B, 2D and 2E) [11]. Given the reported relationship
between Cno and Ras or N signaling pathways in different systems
(see introduction), we hypothesized that Cno could be modulating
both Ras and N signaling during muscle progenitor formation.
Figure 2. cno
2 zygotic null mutants display gain and loss of progenitors. All panels show lateral views of stage 11 embryos stained with an a-Eve
antibody. (A) Eve wildtype (wt) expression in a subset of dorsal muscle/heart progenitors and founder cells (2–3 cells) per hemisegment. (B) cno
2
mutants show gain (arrow), loss (arrowhead) or a wildtype number (asterisk) of Eve
+ progenitors in different hemisegments. (C) Embryos in which
N
Act, Wg and Ras
Act are simultaneously expressed in the mesoderm display a cno
2-like phenotype: gain (arrow), loss (arrowhead) and wildtype
number of Eve
+ progenitors (asterisk). (D) Overexpression of Ras1
Act in the mesoderm induces the specification of extra Eve
+ progenitors. (E)
Overexpression of N
Act in the mesoderm inhibits Eve
+ progenitor specification. (F) Embryos in which Wg is overexpressed in the mesoderm show gain
of Eve
+ progenitors in intersegmental regions (arrow). (G) Table shows % of embryos of the indicated genotype that display a wildtype number of
Eve
+ progenitors, Eve
+ progenitors gain, loss and both (gain and loss). cno
2 and cno
mis1 are null and hypomorph mutant alleles, respectively; Df(3R)
6-7
removes cno. cno gof phenotype (UAS-cno) is also variable. Legends for bars are shown below the table. At least 70 embryos of each genotype were
counted. P,0.0001 for all genotypes except for cno
mis1 (P=0.0017).
doi:10.1371/journal.pone.0000066.g002
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pathways during progenitor specification.
cno genetically interacts with N and Ras signaling
pathways during progenitor specification
A classical genetic approach to uncover gene interactions during
biological processes is the analysis of transheterozygous mutant
phenotypes. Thus, to determine if Cno was interacting with N
signaling during progenitor specification, we examined Eve
expression in embryos with reduced doses of cno and different
components of the N signaling pathway, including Dl, the ligand
of N required for progenitor specification, and N itself. For
example, double heterozygotes of cno and Dl (cno
2/Dl
X) showed
a great expansion of Eve
+ progenitors, which was not observed in
the single heterozygotes cno
2/+ and Dl
X/+ (Fig. 3B and 3U).
Further genetic interactions (Fig. 3G, 3U and not shown) indicated
that cno interacts with N signaling during muscle progenitor
formation.
In a similar way, transheterozygous mutant analysis revealed
strong genetic interactions between cno and Ras pathway
components, including pointed (pnt), which encodes an ETS-domain
effector of Ras signaling [44] and Ras itself (Fig. 3 and not shown).
For example, double heterozygotes for cno and pnt (cno
2/pnt
D88)
showed a great loss of Eve
+ progenitors, which was not observed in
the single heterozygotes cno
2/+ and pnt
D88/+ (Fig. 3C and 3U).
Additional genetic interactions (Fig. 3H, 3E, 3J, 3U and not
shown) indicated that Cno functions with Ras signaling during
progenitor specification. In summary, our data revealed genetic
interactions between Cno and both N and Ras-MAPK signaling
pathways.
cno interacts genetically with Wg signaling pathway
The canonical Wg signaling pathway is another critical compo-
nent for dorsal muscle/heart progenitor specification. wg lof
mutants show a loss of Eve
+ progenitors, whereas Wg over-
expression in the mesoderm induces extra Eve
+ progenitors; these
additional progenitors frequently appear in intersegmental regions
[10,45] (Fig. 2F). Intriguingly, the extra Eve
+ progenitors specified
in cno
2 null mutant embryos were often observed in intersegmental
regions (Fig. 2B). Furthermore, Cno has been shown to interact
genetically with some components of the Wg pathway during wing
morphogenesis [24,46]. Hence, we investigated whether cno
genetically interacted with components of the Wg pathway during
progenitor specification. Transheterozygotes for wg and cno
(wg
CX4/+; cno
2/+) revealed a strong interaction (Fig. 3D and 3U).
Additional genetic interactions were found between cno and
components of the canonical Wg pathway that further supported
a functional relationship between Cno and Wg pathway during
progenitor specification (Fig. 3I, 3U and Fig. 4, see below).
Cno inhibits N, Ras and Wg signaling pathways
Our genetic data indicated that Cno interacts with Wg, Ras and N
signaling pathways throughout the process of dorsal muscle
progenitor specification. These three signaling pathways act as
positive (Wg and Ras) and negative (N) signals during progenitor
formation [10]. We hypothesized that Cno regulates the relative
thresholds of those positive and negative signals throughout
progenitor specification. To further understand how Cno affects
Wg, Ras and N signaling pathways during this process, we
analyzed in more detail the functional relationships between Cno
and each of these pathways.
Several experiments revealed an inhibitory effect of Cno on N
signaling. For example, the cno overexpression phenotype was
enhanced when N activity was reduced (Dl
X heterozygous
background) (Fig. 4). In addition, the N effector and transcrip-
tional repressor, E(spl)-m8, was upregulated in cno
2 null mutants
(Fig. S2C and S2D). Thus, Cno showed an antagonist effect on N
signaling.
Additional genetic interactions between Cno and the RTK-Ras-
MAPK pathway also suggested an inhibitory effect of Cno on Ras-
MAPK signaling during progenitor specification. For example, the
Ras
Act overexpression phenotype was enhanced in a cno
2 homo-
zygous background (Fig. 3T). In addition, examples of synergism
between Cno and negative regulators of Ras signaling were found
(Fig. 3E, 3J and Fig. S3). These genetic data supported a repressive
effect of Cno on Ras-MAPK signaling.
Lastly, our experiments suggested that Cno, under wildtype
conditions, also antagonized canonical Wg signaling. For example,
we found that cno lof dominantly enhanced the overexpression
phenotype of Wg, Dsh and Armadillo (Arm)/b-catenin [47]
(Fig. 4). In addition, cuticles from cno
2 mutant embryos showed
a naked phenotype, characteristic of Wg overexpression (not
shown). These genetic interactions, in addition to the cno
2 null
mutant phenotype, suggested that Cno has an inhibitory effect on
canonical Wg signaling.
Altogether, our genetic data supported an inhibitory effect of
Cno on N, Ras-MAPK and Wg signaling pathways. We thus
expected an increase in activity of all these signaling pathways in
cno
2 mutants. Indeed, the simultaneous overexpression of Wg, N
Act
and Ras
Act in the mesoderm phenocopied the cno
2 null mutant
phenotype (Fig. 3F, 3K, and 3P). Furthermore, the phenotypes
observed by reducing N, Ras or Wg signaling in cno
2 mutants
resembled those found by simultaneously overexpressing Wg-
Ras1
Act,N
Act-Wg or N
Act-Ras
Act, respectively (compare Fig. 3G,
3L, 3Q; 3H, 3M, 3R and 3I, 3N, 3S). The inhibitory effect of Cno
on N, Ras and Wg signaling pathways may seem in conflict with
the phenotypes observed in some of the genetic combinations for
cno and components of the N, Ras or Wg pathways (Fig. 3).
However, the upregulation of both positive and negative signals in
cno
2 mutant embryos can explain the net effect on Eve expression
found in the different genetic combinations. For example, in cno
2/
cno
2, pnt
D88 embryos (Fig. 3H and 3M), there is an increase in all
three signals: the two positive (Ras, Wg) and one negative N signal.
However, the Ras pathway is impaired in these embryos (pnt
D88/+
genetic background). In addition, N signaling, which down-
regulates the Ras pathway [11], increases in cno
2/cno
2, pnt
D88
embryos. Hence, the net effect is a great reduction of the positive
Ras signal and thus, a great reduction of Eve expression.
Cno physically interacts with N and Dsh
Wg, Ras and N signaling pathways are critical for muscle
progenitor specification: Wg signaling first sets up a region of
competence, in which Ras and N will subsequently be locally
activated to specify a single progenitor (Fig. 1). Our mutant
analysis and genetic interaction data suggested that Cno
antagonizes all three pathways, Ras-MAPK, N and Wg, during
progenitor specification. The reported direct binding of Cno/AF-6
to Ras
Act [34] could explain the Cno repressive effect on Ras-
MAPK signaling. Indeed, AF-6 competes with Raf-1, a main Ras
effector, for binding Ras [34]. We confirmed this physical
interaction between Cno and Ras
Act (Fig. 5D). To understand
how Cno inhibited N and Wg signaling, we examined potential
physical interactions between Cno and members of the N and Wg
signaling pathways. Both N and Dsh, a key Wg effector, have the
consensus binding site for the PDZ domain of Cno/AF-6 at their
C-terminus [48]. Hence, we analyzed physical interactions
between Cno, N and Dsh.
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embryonic lysates and in vitro translated proteins. These experi-
ments showed that Cno coimmunoprecipitates with both N and
Dsh (Fig. 5A, 5B and Fig. 7I). The co-IPs from embryonic lysates
showed different sizes of the Cno proteins coimmunoprecipitated
with either Dsh or N (Fig. 5A). We suggest that some of these
different forms of Cno are due to different post-translational
modifications in each of those complexes, different isoforms of
Cno or/and specific breakdown products of Cno (See also Fig. S5).
To characterize the domains implicated in the binding, diverse
deletion constructs of Cno, N and Dsh were tested in yeast two-
hybrid assays (Fig. 5C and 5D). Only Cno constructs comprising
the PDZ domain strongly interacted with both proximal (Notch-
ICN1) and distal (Notch-ICN2) regions of the N intracellular
Figure 3. cno interacts genetically with N, Ras and Wg signaling pathways. (A–J and P–T) Lateral views of stage 11 embryos stained with an a-Eve
antibody. (B, G) Extra Eve
+ progenitors are detected both in cno
2/Dl
X transheterozygotes and in cno
2/cno
2, Dl
X embryos. (C, H) Both cno
2/pnt
D88
double heterozygotes and cno
2, pnt
D88/cno
2 embryos show loss of Eve
+ progenitors. (E, J) An increase in Eve
+ progenitors is observed both in cno
2/
aos
D7 transheterozygotes and in cno
2, aos
D7/cno
2 embryos [74]. (D, I) Gain and loss of Eve
+ progenitors are detected both in wg
CX4/+; cno
2/+ double
heterozygotes and in wg
CX4/+; cno
mis1/cno
2 embryos. (F–I, K–N, P–S): (P) Simultaneous mesodermal overexpression of N
Act-Wg-Ras
Act, (Q) Wg-Ras
Act,
(R) N
Act-Wg and (S) N
Act-Ras
Act have similar phenotypes than cno
2/cno
2 (F, K), cno
2/cno
2, Dl
X (G, L), cno
2/cno
2, pnt
D88 (H, M) and wg
CX4/+; cno
mis1/cno
2 (I,
N) embryos, respectively. Arrows and arrowheads indicate gain and loss of progenitors, respectively. (K–O) Diagrammatic representation of the effect
on Eve expression of cno lof (K) and cno lof in combination with reduced doses of N (L), Ras (M) and Wg (N) signaling components, or with increased
doses of Ras signal (O). (T) The phenotype of Ras1
Act mesodermal overexpression is enhanced in a cno
2 mutant background. (U) Table shows % of
embryos of the indicated genotype that display a wildtype number of Eve
+ progenitors, Eve
+ progenitors gain, loss and both (gain and loss). Legends
for bars are shown right to the table. At least 70 embryos of each genotype were counted. P,0.0001 for all genotypes except for cno
2/cno
2, aos
D7
(P=0.0239) and wg
CX4/+; cno
2/cno
mis1 (P=0.006).
doi:10.1371/journal.pone.0000066.g003
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The Cno-Dsh interaction, however, mapped to two different
domains of Cno: the PDZ domain and the Ras-binding domain
(Fig. 5C and 5D). To distinguish which domains in Dsh bound the
Ras-associating and PDZ motifs of Cno, different Dsh constructs
were tested. A Dsh fragment containing the DIX (DIshevelled,
aXin) and PDZ domains (DSH-DIZ) only bound Cno constructs
containing the Ras-binding domain, as did the Ras positive control
(Fig. 5C and 5D). In contrast, the Dsh fragment containing the
DEP (Dsh, egl-10, pleckstrin) domain (DSH-DEP) only bound
Cno constructs containing the PDZ domain plus some of the
adjacent Myosin-V (Myo)-like domain (Fig. 5C and 5D). Thus,
these data indicated that Cno physically interacted with both N
and Dsh. These physical interactions could lead to the inhibitory
effects of Cno on N and Wg-Dsh signaling pathways.
Cno links Wg-Dsh and Dl-N signaling pathways
Dsh has been shown to interact physically with N and to inhibit
its signaling during Drosophila wing bristle development [49]. We
found that, genetically, Dsh also acted antagonistically to N
signaling during muscle/heart progenitor specification (Fig. S2A,
S2B and Fig. 4). For example, the phenotype of Dsh mesodermal
overexpression was enhanced by reducing N signaling activity
(Dl
X/+ genetic background) (Fig. 4). However, the mechanism
underlying the Dsh-N antagonism is unclear: the reported Dsh-N
(Notch-ICN2) physical interaction was very weak under our
conditions (approximately 3 fold activation, Fig. 5D; see also
Discussion) [49,50]. Moreover, Dsh failed to co-immunoprecipi-
tate in vitro with N under our conditions (Fig. 5B). Hence,
although Dsh had an antagonistic effect on N signaling during
muscle progenitor specification, our data did not support a strong
physical interaction between Dsh and N as the means by which
Dsh inhibits N signaling. Dsh has been shown to co-immunopre-
cipitate with N in vivo [51]. This interesting finding supports that
Dsh and N are forming part of a complex during embryogenesis.
However, it is not a proof of a direct physical interaction between
both proteins. Since (1) Cno had a negative effect on N signaling,
Figure 4. Cno inhibits Wg-Dsh pathway and links it with Dl-N pathway.
Table shows % of embryos and hemisegments (Hs) for each indicated
genotype that display extra Eve
+ cells. At least 70 embryos/770
hemisegments were counted in each case. P,0.001 for all genotypes
except for UAS-wg; cno
2/+, ‘‘% Embryos bar’’ (P=0.0027); UAS-arm
S10,
cno
2/+, ‘‘% Embryos bar’’ (P=0.0337); UAS-cno, Dl
x/+, ‘‘% Embryos bar’’
(P=0.0177); UAS-dsh, UAS-cno, Dl
x/+, ‘‘% Embryos bar’’ (P=0.0472);
UAS-dsh, UAS-cno, ‘‘% Embryos bar’’ (P=0.0115), ‘‘% Hs bar’’
(P=0.0002).
doi:10.1371/journal.pone.0000066.g004
Figure 5. Cno physically interacts with Dsh and N. (A) Coimmunopre-
cipitations from embryonic lysates. Left panel: Cno is coimmunopreci-
pitated with endogenous Dsh. Right panel: Cno is coimmunoprecipi-
tated with endogenous N. Different sizes of the Cno protein
coimmunoprecipitated with Dsh and N (see text). A Rat and Rb sera
without the Dsh or N antibodies were used as negative controls. (B) In
vitro coimmunoprecipitations (see also Fig. 7I). Left panel: HA-tagged
Dsh (DSH-FLN) does not coimmunoprecipitate with N. Right panel: HA-
tagged Cno (CNO-NH) coimmunoprecipitates with Myc-tagged N
(Notch-‘‘intra’’). In each panel, lanes 1 and 2:
35S-labelled (*) protein,
HA-tagged, without adding any antibody (Ab) (lane 1) or adding a-Myc
Ab (lane 2), as negative controls; lanes 3 and 4: *proteins HA-tagged
(lane 3) or Myc-tagged (lane 4) tested with the corresponding Ab; lanes
5 and 6: translation products; lane 7: coimmunoprecipitation of the
*HA-tagged protein with the Myc-tagged protein by an a-Myc-Ab. (C) N
intracellular domain (Notch-‘‘intra’’), Dsh and Cno constructs used in the
yeast two-hybrid and co-IP assays (see also ‘‘Materials and methods’’).
(D) Yeast two-hybrid: averaged results of at least four independent
protein extracts in b-galactosidase quantitative liquid assays. The fold
activation determined with respect to the corresponding empty vector
is represented. Bars indicate s.e.m. DSH-FLN, CNO-NH, CNO-RA and
CNO-MP were tested against Notch constructs: Notch-ICN1 and Notch-
ICN2. DSH-FLN, DSH-DEP, DSH-DIZ and RAS
V12 were tested against
different Cno constructs (C).
doi:10.1371/journal.pone.0000066.g005
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proteins directly interacted in vitro and in yeast two-hybrid assays
and (4) Cno interacted physically with Dsh, we reasoned that Cno
could mediate the repressive effect of Dsh on N signaling.
To test this function of Cno as a mediator of the inhibitory effect
of Dsh on N, we performed several genetic experiments. For
example, the phenotype of Dsh overexpression under conditions of
reduced N activity (Dl
X/+ genetic background, see above) was
further enhanced by the simultaneous overexpression of Cno
(Fig. 4). This result supported a function of Cno in mediating the
N repression by Dsh. The relevance of Cno-Dsh interaction to
inhibit N signaling was further supported by using specific deletion
constructs of Dsh (DshDDEP) and Cno (CnoDN) that cannot
interact with each other. Whereas the simultaneous mesodermal
overexpression of wildtype forms of Dsh and Cno led to a great
increase of Eve
+ cells (a N lof phenotype), the simultaneous
overexpression of DshDDEP (lacks the DEP domain) [52] and
CnoDN (lacks the RA1 and RA2 domains) [53] (see also Fig. 5)
showed a much weaker effect, consistent with the existence of
more N activity in the mesoderm of these embryos (Fig. 4;
compare with overexpression of wildtype forms of Dsh and Cno).
The DEP domain of Dsh is required to relocate Dsh at the
membrane [54]. Given the physical interaction between Cno and
the region of Dsh that contains the DEP domain, we next
examined whether Cno was affecting Dsh cell localization. Cno
overexpression in the mesoderm led to a striking accumulation of
both Dsh and N close to the membrane of Eve
+ interacting cells
(arrows in Fig. 6B, 6D and 6F; compare to 6A, 6C, and 6E). This
observation suggested that the negative effect of Cno on N and
canonical Wg pathway could be related to the accumulation of
Dsh and N at the cell membrane (see Discussion). Taken together
with the genetic and physical interaction data, these results
supported a cross-regulatory interaction between N and Dsh
mediated by Cno during progenitor formation.
Cno links Wg-Dsh and Ras-MAPK signaling pathways
Wg signaling provides mesodermal cells competence to respond to
Ras signaling, in part through the requirement of Wg to maintain
the expression of different components of the Ras pathway [55].
For example, in wg mutant embryos, we detected reduced
expression of the Drosophila FGF receptor Htl, as well as no
expression of diP-MAPK, a measure of Ras activation (Fig. 7C
and 7G; [56]). However, the molecular mechanism by which this
competence is achieved, either by direct regulation or indirectly
Figure 7. Wg-Dsh signaling releases Cno-mediated Ras repression.
(A–H) Lateral views at high magnification (636) of stage 11 embryos
showing three hemisegments. (A, C, E) In wg
CX4 mutants neither diP-
MAPK (green) nor Eve (blue) expression is detected in the mesoderm,
which is marked by Twi (red). (G) The FGFR Htl (red) is also
downregulated in wg
CX4 mutants. (B, D, F, H) Both diP-MAPK (B, D)
and Htl (H) expression are rescued in wg
CX4; cno
mis1 double mutants;
Eve expression is not rescued (F). tp, tracheal pits. (I) Dsh competes with
Ras for binding Cno. Proteins were translated in vitro in presence (*) or
absence of
35S-Methionine. Lane 1 and 2: *Ras
V12 and *Dsh, both HA-
tagged, were immunoprecipitated with an a-HA antibody (Ab). Lane 3:
Both *Ras
V12 and *Dsh were co-IP with Cno by an a-Myc Ab. Lane 4, 5
and 6: The addition of increasing amounts of Dsh leads to a decrease in
the amount of *Ras
V12 co-IP with Cno.
doi:10.1371/journal.pone.0000066.g007
Figure 6. Overexpression of Cno leads to the stabilization of Dsh and N
close to the membranes of Eve
+ interacting cells. The most dorsal part
of two hemisegments of stage 11 embryos are shown in all panels (636
magnification). Eve marks a dorsal equivalence group in the mesoderm
(blue). (A, C, E, G) In wildtype (WT) embryos, Dsh (green) and N (red)
colocalize at some regions in Eve
+ cell clusters (arrows). (B, D, F, H) Cno
overexpression (UAS-cno) leads to an increase of Dsh and N close to the
membranes of Eve
+ cells (arrows).
doi:10.1371/journal.pone.0000066.g006
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Cno bound and inhibited Ras, and the Wg effector Dsh bound the
Cno Ras-associating domain, we hypothesized that Wg signaling
would release Cno-mediated Ras inhibition through competition
between Dsh and Ras for the Cno Ras-binding domain.
Therefore, we predicted that some Ras activity would be rescued
in wg mutants in which Cno is no longer present to repress Ras.
To test this hypothesis, we analyzed MAPK activity and the
expression of proteins under Ras regulation in wg
CX4; cno
mis1
double mutants. DiP-MAPK expression, which is lost in wg
CX4
mutants (Fig. 7A and 7C, compare to Figure S3A and S3B) [55],
was partially rescued in wg
CX4; cno
mis1 double mutants (Figure 7B
and 7D). This was the same level of rescue obtained in wg
CX4
mutant embryos by overexpression of Ras
Act [55]. As expected,
Eve expression was not rescued in wg
CX4; cno
mis1 mutant embryos
(Fig. 7A, 7B, 7E and 7F) nor is it rescued in wg
CX4 mutant embryos
by Ras
Act, as Eve expression, in addition to Ras, requires a direct
transcriptional input from Wg signaling [10,55,57]. Moreover, the
expression of the Drosophila FGF receptor Htl [58], which is
downregulated in wg
CX4 mutant embryos, was also rescued in
wg
CX4; cno
mis1 double mutants (Fig. 7G and 7H) [55]. Since Ras-
MAPK upregulates Htl expression [11], the increase of Htl
expression in wg
CX4; cno
mis1 double mutants was consistent with the
rescue of MAPK activity found in these embryos. These results
suggested that Wg signaling releases the Ras repression mediated
by Cno.
To further investigate how Wg signaling releases the Ras
repression mediated by Cno, we examined the possible function of
Dsh, which is activated upon Wg signaling, in this process. We
found that diP-MAPK expression was lost in dsh
V26 lof mutants
and expanded in dsh gof mutants (Fig. S4). Since Dsh physically
interacted with the Ras-binding domain of Cno (Fig. 5, see also
Fig. 8A), we next tested whether Dsh competes with Ras for
binding Cno. We found that addition of increasing amounts of
Dsh led to reduced amounts of Ras
V12 (Ras
Act) co-immunopre-
cipitated with Cno (Fig. 7I). Thus, Dsh was able to compete with
Ras for binding Cno. Altogether, these experiments strongly
suggested that Wg-Dsh signaling activates eve during muscle/heart
progenitor specification both by direct binding of dTCF/Arm to
the eve muscle enhancer [55] and by releasing the Ras repression
mediated by Cno.
DISCUSSION
Elucidating crosstalk mechanisms and regulation is fundamental to
the understanding of how cells integrate the complex information
that they receive from their environment to generate precise cell
responses [1]. In this study, we argue that the PDZ-domain
containing protein Cno/AF-6 is a key modulator of Ras-MAPK,
N and Wg/Wnt signaling pathways cross-communication: (1) Cno
is expressed during muscle progenitor formation, (2) Cno
colocalizes in vivo and genetically interacts with components of
these three pathways, which are critical to muscle progenitor
specification and (3) Cno represses each of these pathways through
physical interactions with Ras
Act, Dsh and N. We propose that
Cno, through those interactions, coordinates and integrates the
information required by cells to adopt the progenitor fate.
Cno represses Ras-MAPK, N and canonical Wg/Wnt
signaling pathways
A body of evidence suggests that Cno/AF-6 represses the Ras-
MAPK signaling pathway [34,35,59,60]. In this work, we present
further data that strongly support the inhibition of Ras-MAPK
signaling by Cno in vivo. The repression of Ras-MAPK signaling
by Cno does not account, however, for all the phenotypes detected
in cno
2 mutant embryos, such as cases of Eve
+ progenitor losses (i.e.
if Cno were merely inhibiting Ras, in cno
2 mutant embryos there
would be more positive Ras signaling and, thus, only more Eve
+
progenitors should be found). In this work, we provide data that
support an inhibitory effect of Cno on N signaling during muscle
and heart progenitor specification. Since N inhibits progenitor
fate, the cases of Eve
+ progenitors losses found in cno
2 mutants can
be explained by the increase in N signaling in cno
2 mutants.
Indeed, an increase in E(spl)-m8 expression, a main effector of N
signaling, was detected in cno
2 mutants (Fig. S2C, S2D). Given that
Cno interacted physically with N and that the overexpression of
Cno led to an accumulation of N at the membrane, one possibility
is that Cno inhibits N signaling by impeding the cleavage of N
from the membrane. Other possibilities are that Cno interferes
with N endocytosis and vesicular trafficking, both key processes in
Figure 8. Summary of physical interactions and working model. (A)
Diagram summarizing the physical interactions between Cno and
Nintra, Ras
Act and Dsh. (B) Working model. The modulation of the
information conveyed by three signaling pathways, Wg, N and Ras-
MAPK, is critical for muscle progenitor specification. Our data show that
Cno interacts physically and genetically with these three pathways,
negatively regulating the information flow to key progenitor transcrip-
tional targets, L’sc and Eve. In this model, the Cno/Dsh interaction is
pivotal to modulate signaling thresholds. Cno/Dsh interaction facilitates
the release of Cno repression on Ras
Act signaling and the inhibition of N
signaling by Cno. Dsh recruitment by Cno leads to canonical Wg signal
inhibition. Arr, Arrow; Fz2, Frizzled2.
doi:10.1371/journal.pone.0000066.g008
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to test these hypotheses.
The repression of both Ras-MAPK and N signaling by Cno still
cannot account for all the phenotypes observed in cno
2 mutants,
such as the extra Eve
+ cells that appeared in intersegmental
regions. This phenotype is characteristic of Wg overexpression
suggesting that, in wildtype conditions, Cno is also repressing Wg
signaling. Indeed, we present data in this work that support a Cno
inhibitory effect on canonical Wg signaling. Since Dsh and Cno
interacted physically, one possibility is that Cno interrupts Wg
signaling at the level of Dsh, perhaps by sequestering Dsh away
from other pathway components or by diverting it to other non-
canonical roles.
Hence, a repressive effect of Cno on both negative (N) and
positive (Wg and Ras-MAPK) signals required for progenitor fate
could ultimately explain the variable phenotypes found in cno lof
and gof mutants (Fig. 2). For example, in cno
2 mutants there will be
more positive Ras and Wg signals, but also more negative N signal
(Fig. 3K); and Cno overexpression will lead to less positive Ras and
Wg signals, but also to less repressive N signal. Thus, the final net
balance of positive and negative signals would determine the
variable phenotype observed in cno
2 zygotic null mutant embryos.
A maternal contribution of cno has been reported [63]. This
maternal contribution might be masking the complete lof
phenotype of cno (i.e. a ‘‘not-variable’’ phenotype). However, we
favour the hypothesis that the variable phenotype observed in cno
zygotic mutants is due to the Cno regulation of both positive and
negative signals required for progenitor fate. Thus, we would
expect that different thresholds of Cno protein (from the complete
lof condition to a gof condition) would cause a variable phenotype.
Indeed both a hypomorph allele of cno (cno
mis1) and cno gof showed
that variable phenotype (Fig. 2G). Given the reported relationships
between Cno and Ras, N or Wg in different developmental
contexts, Cno could be a general link and modulator of these
signaling pathways throughout development.
How is Cno linking Ras, N and Wg signaling
pathways?
We propose a working model to explain how Cno is mediating
Ras, N and Wg cross-talk during progenitor specification (Fig. 8B).
First, just before Wg signaling begins, Cno directly interacts with
Ras
Act and inhibits its ability to signal. As a result of Wg signal
activation, L’sc starts to be expressed in the mesoderm [10]. Then,
L’sc upregulates Dl expression in the mesoderm (A.C., un-
published data, not shown in the model), which in turn activates N
in nearby cells, initiating the process of lateral inhibition in the
equivalence groups. At the same time, Dsh activation by Wg
would result in a competition between Dsh and Ras for the Cno
Ras-binding domain. Consequently, Ras repression by Cno is
released; this leads to the upregulation of L’sc and to the activation
of the identity gene eve, which requires both Ras-MAPK and Wg
signaling for its expression. The binding of Cno to the Dsh DEP
domain facilitates the localization of both Dsh and Cno at the
membrane. This would have two consequences: (1) the in-
activation of the Wg signaling through the canonical pathway
and (2) the repression of N signaling by Cno physical interaction.
Whether Dsh is phosphorylated or unphosphorylated when
forming part of the Cno-Dsh complex is something that will be
pursued in future studies.
Thus, Cno links Ras and N pathways through its binding to
Dsh: Dsh-Cno interaction would facilitate both Ras signaling
activation and N signaling inhibition. By directly interacting with
Ras
Act, Dsh and N and by locating these proteins in close
proximity, Cno would actively coordinate Wg with Ras and N
signaling pathways, allowing their cross-communication and
modulating their relative signal thresholds throughout progenitor
specification. Our data imply that Wg/Dsh is not only a critical
permissive signal for the initial mesoderm patterning, but also this
signal would play an important role later, during the process of
lateral inhibition, in combination with Ras and N. The complexes
Cno-Ras, Cno-Dsh, and Cno-N would be in a dynamic equilib-
rium. The thresholds and relative affinities of all these proteins,
their spatio-temporal control and, ultimately, the specific cell
context would dictate the binding state and activity of Cno.
Cno role as a mediator between Wg-Dsh and N
signaling pathways
Dsh has been shown to bind N by using yeast two-hybrid assays
[49,50]. Dsh has also been shown to coimmunoprecipitate with N
in vivo [51]. However, both our yeast two-hybrid and in vitro co-
IP experiments did not support a direct Dsh-N interaction. Our
experiments showed that Cno physically interacts with N by using
both yeast two-hybrid and co-IP assays. Thus, the described
inhibitory effect of Dsh on N signaling [49] is likely to be mediated
through Cno, by directly binding N. Yet, other possibilities could
explain our observations. For example, a weak physical interaction
between Dsh and N may require the presence of Cno to
strengthen it; this could be achieved by the simultaneous binding
of Cno to Dsh and N. Another possibility is that the complex Cno-
Dsh facilitates a post-translational modification of Dsh required
for binding N, which is not occurring under our experimental
conditions. Indeed, Dsh is a phosphoprotein that becomes
hyperphosphorylated upon Wg signaling [64]. Our working model
takes into account the following observations: Cno bound both
Dsh and N, Dsh did not clearly bind N, both Dsh and Cno
interacted antagonistically with N and the interaction between
Dsh and Cno was important for N inhibition. Additional
experiments are required to further clarify the functional relation-
ships among these proteins.
Conclusions
Multiple points of cross-communication among signaling pathways
are crucial to ensure a fine-tuned regulation of signaling networks.
Integration of signals at the enhancer level has been shown to be
an essential mechanism to achieve specific and coordinated
responses [55]. In this study we show how regulation at the mem-
brane level through Cno and Dsh, two PDZ domain-containing
proteins, is also critical to elicit signaling pathways integration.
Multiprotein complex formation around PDZ-based scaffolds at
specific sub-membrane locations is known to be decisive for signal
transduction rate and fidelity [29,30]. Thus, PDZ proteins are
excellent candidates as points of crosstalk at the membrane level.
Here, we show a dynamic role for a PDZ protein, modulating the
thresholds of multiple signal transduction pathways in vivo. Future
investigation will allow a further understanding of how these
proteins organize and regulate the complex cell networks of
signaling pathways.
MATERIALS AND METHODS
Drosophila strains and genetics
The following mutant stocks were used: cno
2, cno
mis1 [24], Df(3L)
6-7,
Dl
X, aos
D7, pnt
D88, wg
CX4, dsh
V26, Ras1
e2F,N
X81K1. Ectopic expres-
sion was achieved with the GAL4-UAS system [65] and the
following fly lines: twi-GAL4, Dmef2-GAL4, UAS-Ras1
Act, UAS-N
Act,
UAS-wg, UAS-cno [35], UAS-cnoDN [53], UAS-arm
S10, UAS-dsh and
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bination to analyze the effect on Dsh expression. All the crosses
Gal4-UAS were carried out at 29uC. twi-GAL4 and Dmef2-GAL4
drivers were used in combination for all overexpression experi-
ments, except for overexpression of Ras1 in a cno
2 homozygous
background; in this case, only the twi-GAL4 driver was employed.
Other lines used in this work were: twi-CD2 [66] and dsh-GFP [52].
yw was used as the reference wildtype strain. Balancer chromo-
somes containing different lacZ transgenes were used for
identification of homozygous mutant embryos.
Immunohistochemistry, in situ hybridization and
microscopy
Embryo fixation, antibody staining and in situ hybridization were
carried out by standard protocols [10]. The following primary
antibodies were used: rabbit a-Cno, 1/500 [25]; rat a-Cno [53],
mouse a-CD2, 1/800 (Serotec); rat a-L’sc, 1/800 [67]; rabbit a-
Eve, 1/3000 [68]; mouse a-Eve, 1/25 (Hybridoma Bank); guinea
pig a-Eve, 1/200 [69]; guinea pig a-Kr, 1/2000 [69]; mouse a-Dl,
1/40 (M. Muskavitch); rabbit a-Htl 1/1000 [42]; rabbit a-b-
galactosidase 1/100000 (Cappel); mouse a-b-galactosidase 1/8000
(Promega); mouse a-diP-MAPK, 1/400 (Sigma); rabbit a-Twi,
1/1000 (S. Roth); mouse a-N 1/100 (Hybridoma Bank); mouse
a-GFP, 1/400 (Clontech); rat a-Dsh, 1/500 [70], mAb 3E2 [5].
For immunostaining with the a-Cno antibody, embryos were fixed
by using the heat-methanol method [71]. L’sc and diP-MAPK
signals were enhanced by use of Tyramide Signal Amplification
reagents (New England Nuclear). Fluorescent images were
recorded by using a Zeiss LSM 510 Axiovert 100M microscope
and assembled by using Adobe Photoshop. Blinded scoring of
Notch and Dsh staining in the wildtype and cno overexpression
studies (Fig. 6) was performed.
Statistical analysis
The phenotypic effects of individual mutations in various genetic
backgrounds were tested for significance (P,0.05) with pairwise
comparisons of genotypes by a standard Fisher test.
Yeast two-hybrid assays and cloning
Yeast transformations and b-galactosidase quantitative liquid
assays were carried out following Clontech User Manual protocols.
Dsh constructs (DSH-FLN and DSH-DEP, in the bait vector
pEG202/LexA) as well as N constructs (ICN1 and ICN2, in the
prey vector PJG-4/pB42AD) were previously described [49].
DSH-DIZ comprising amino acids (aa) 1 to 393 was subcloned in
the same bait vector, LexA. Cno-NH, in the prey vector pACT2,
and Ras
V12, in the bait vector pAS2-1, were previously described
[35]. Other Cno constructs used in this work were: Cno-RA
(containing the two Ras-associating domains, aa 1-355), Cno-MP
(comprising Myo-like and PDZ domains, aa 503-935), Cno-PDZ
(aa 836-935), Cno-M (aa 503-754) and Cno-*MP (comprising
a truncated Myo-like domain and the whole PDZ domain, aa 521-
935). All these Cno fragments were PCR amplified, subcloned into
the prey vector pACT2 and verified by sequence analysis. Western
Blots confirmed expression of the fusion proteins (not shown). Cno
NH, Cno-RA and Cno-MP were also subcloned in the bait vector
LexA. Yeast strains L40 [72] or PJ69-4A [73] were transformed
with the corresponding bait vector. Four to six colonies were tested
for basal b-galactosidase activity and one picked for further
transformation with the prey vector (with the insert and without
any insert as control). Six colonies, harboring bait and prey
vectors, were assayed for b-galactosidase activity. This assay was
repeated at least four times with independent protein extracts. The
activity was represented as fold activation with respect to the
empty vector.
Coimmunoprecipitation assays
Co-IP’s from embryonic lysates: Proteins extracts from 0–7 h-old
fly embryos were homogenized and incubated for 45 min at 4uC
in lysis buffer (50 mM Tris pH 8, 150 mM NaCl, 1 mM EDTA,
1% Triton X-100, 0.1% SDS) containing phosphatase and
protease inhibitors (1 mM NaF, 100 mM NaVO4, 1 mM PMSF
and protease inhibitor complete cocktail from Roche). Protein
extracts were incubated overnight at 4uC with the appropriate
antibody (Rat a-Dsh or Rb a-Notch) 1/1000. Extracts were
filtered and incubated with Protein A beads (Sigma) 2 h at room
temperature (RT). Beads were washed 2 times (15 min each) and
bound proteins were separated on SDS gels and immunoblotted.
Rat (or Rb) a-Cno antibody and HRP-coupled secondary
antibodies were used 1/5000 and 1/2000, respectively. Co-IP’s
with in vitro translated proteins: Proteins were translated using the
TNT Coupled Reticulocyte Lysate Systems (Promega) according
to the manufacturer’s instructions, in presence or absence of
L-[
35S]-Methionine (Amersham). The in vitro coimmunoprecipi-
tations were carried out following the directions of BD Biosciences
Matchmaker Co-IP Kit User Manual. A N construct containing
the whole intracellular domain was used for the co-IP’s (Notch-
‘‘intra’’; Fig. 5C). Proteins were Myc (Cno and N) or HA tagged
(Dsh, Ras
V12 and Cno for the co-IP experiment with N-Myc). a-
HA and a-Myc antibodies were from BD Biosciences. For the
competition assay, in vitro translated proteins Cno and
35S-
Methionine-labeled Ras
V12 were incubated at RT for one hour.
Then, different amounts of in vitro translated Dsh were added.
After one hour at RT, 10 ml of c-Myc Monoclonal Antibody was
added; the reactions were incubated overnight at 4uC for co-IP
Cno-Dsh/Cno-Ras
V12 complexes. These complexes were resolved
on 10% SDS-PAGE minigels. The amount of
35S-Methionine-
labeled Ras
V12 coimmunoprecipitated with Cno was detected by
autoradiography (Kodak BioMax MR).
SUPPORTING INFORMATION
Figure S1 The expression of different proteins required for
progenitor specification is both upregulated and downregulated in
cno2 zygotic null mutants. (A–R) Panels show 636magnifications
of three hemisegments, in a lateral view, of stage 11 embryos. (A)
L’sc (green) and Eve (red) colocalize in a dorsal progenitor singled
out in three adjacent hemisegments. In wildtype embryos, only
L’sc is expressed in the preC2 (inset; see also Fig. 1). (E) In cno2
mutants, L’sc is maintained in the extra progenitors specified and
Eve is detected along with L’sc in the preC2 (inset). (B, F) L’sc
expression in dorsal progenitors (arrows) also fails in some cno2
mutants (arrowheads in F) (NS, nervous system). (C) Kr (green)
and Eve (red) colocalize in a dorsal muscle founder cell per
hemisegment (yellow cells); (G) in cno2 mutants extra Kr+/Eve+
expressing cells are detected (arrows). (D, H) A fraction of cno2
mutants also shows loss of Kr+-expressing founder cells (arrow-
head in H). (I–R) Dl (green in I, J, M–P) and Htl (green in K, L, Q,
R) expression are both upregulated (arrows in O, R) and
downregulated (arrowheads in P, R) in cno2 mutants. (I, J, K, L)
Dl and Htl wildtype expression. Eve+ dorsal progenitors are
shown (red) as reference. (S, T) 406 magnifications, in lateral
views, of late stage 14 embryos showing Eve expression. (S) In
wildtype embryos, Eve is detected in two pericardial cells (arrows)
and one dorsal muscle (dotted line) per hemisegment. (T) In cno2
mutant embryos both loss (arrowheads) and muscle duplications
(dotted lines) are detected; the number of Eve+ pericardial cells is
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of a stage 17 cno2 mutant embryo, in a lateral view, stained with
mAb 3E2 (stains all muscles). In wildtype hemisegments (asterisk),
four lateral transverse (LT) muscles are detected. In some
hemisegments LT muscles are lost (arrowhead) and in other
hemisegments LT muscles are duplicated (arrows).
Found at: doi:10.1371/journal.pone.0000066.s001 (5.29 MB
PDF)
Figure S2 The N effector E(spl)-m8 is upregulated in dshV26
null mutants and in cno2 null mutant embryos. (A, B) The most
dorsal mesoderm of three hemisegments of stage 11 embryos is
shown. (A) In situ hybridization analysis reveals expression of
E(spl)-m8 in the embryonic mesoderm. (B) In dshV26 null mutants
(germ line clones), E(spl)-m8 is widely expressed in the mesoderm.
(C, D) The most dorsal mesoderm of four hemisegments of stage
11 embryos is shown. Eve protein appears in brown and E(spl)-m8
mRNA in blue. (C) In wildtype (WT) embryos E(spl)-m8 is
detected in Eve+ cells (arrows). (D) In cno2 null mutants, E(spl)-m8
is expressed in more cells (arrows). In one hemisegment
(arrowhead), the increase in E(spl)-m8 correlates with the loss of
Eve expression. as, amnioserosa; tp, tracheal pits.
Found at: doi:10.1371/journal.pone.0000066.s002 (7.11 MB
PDF)
Figure S3 Cno represses Ras-MAPK signaling pathway. Three
hemisegments (lateral views) of stage 11 embryos are shown at
high magnification (636). (A–D) In wildtype embryos, diP-MAPK
expression (green) is restricted along with Eve (blue) to the
progenitor. (E–L) An expansion of diP-MAPK expression is
detected both in cno2, aosD7 (E–H) and in cno2, DlX
(I–L) transheterozygotes (arrows). The transcription factor Twist
(Twi, red) marks mesoderm. tp, tracheal pits.
Found at: doi:10.1371/journal.pone.0000066.s003 (3.37 MB
PDF)
Figure S4 Dsh is required for MAPK activity. A 636
magnification of the dorsal mesoderm of three hemisegments is
shown. Eve appears in red, diP-MAPK in green and colocalization
of both in yellow. (A) In dshV26 null mutants, diP-MAPK
expression is not detected in the dorsal mesoderm. Asterisks (*)
mark the normal position of Eve+/diP-MAPK+ cells. (B)
DshDDEP overexpression in the mesoderm leads to expansion
of diP-MAPK (arrows). DshDDEP contains the region that bound
the Ras-associating domain of Cno. tp, tracheal pits. (Wildtype
diP-MAPK/Eve expression is shown in Fig. S3).
Found at: doi:10.1371/journal.pone.0000066.s004 (2.76 MB
PDF)
Figure S5 Two independently generated Cno anti-sera coim-
munoprecipitate Cno protein with Dsh (double arrow). Both Cno
anti-sera recognize three specific bands (arrows in the ‘‘Input
line’’). The Rabbit a-Cno anti-serum recognizes an additional, non
specific band, which is not detected by the Rat a-Cno anti-serum.
The presence of multiple bands for Cno in the input line has been
already published (Takahashi et al., 1998, Mech. Dev. 78, 97–111;
see Figure 11 A).
Found at: doi:10.1371/journal.pone.0000066.s005 (0.60 MB
PDF)
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